Tribune News Network
Doha
Sidra Medicine, a member of Qatar Foundation, has announced its strategic partnership with the Middle East Fertility Society (MEFS) for its upcoming 31st Annual Scientific Meeting on fertility care (MEFS 2024). The event will be held at the Sheraton Grand Doha from November 21 to 23.
MEFS is the largest organisation in the Middle East dedicated to enhancing fertility care for couples in the Arab world and the broader Middle East. Its mission is driven by the transfer of medical knowledge and the promotion of scientific research. MEFS 2024 is expected to welcome over 1,200 attendees.
Dr Johnny Awwad, MEFS 2024 chairman and chair of women’s services at Sidra Medicine, said: “Our partnership with MEFS marks a significant step forward for advancements in fertility care. As a strategic partner of the 31st Annual meeting, Sidra Medicine is proud to bring MEFS 2024 to Doha. We are also positioning the country’s important role in bringing the world’s top medical practitioners and clinical research experts, pioneers and thought leaders together. This collaborative effort will open up new pathways to innovation in reproductive health that will benefit both women and men across the Middle East and worldwide.”
MEFS 2024 will feature a diversity of sessions, workshops and presentations covering the latest breakthroughs, best practices and emerging trends in fertility, reproductive health and Assisted Reproductive Technologies (ART) including ethical and regulatory considerations in ART.
A special debate on IVF Legislation – ‘What can we do in Qatar to initiate governance and regulation’--will be held at the pre-workshop session. Key speakers include Dr Cynthia Morton, William Lambert Richardson Professor of Obstetrics, Gynaecology and Reproductive Biology and Pathology, Harvard Medical School, and Dr Elizabeth S. Ginsburg, president of the American Society of Reproductive Medicine.
Dr Matteo Avella, member of the Local Scientific Committee at MEFS 2024 and principal investigator in the Division of Reproductive and Perinatal Health at Sidra Medicine, said: “We are entering an era of personalized fertility management, where genetics will play a pivotal role in tailoring treatments to individual needs and maximizing fertility outcomes. With Sidra Medicine’s expertise in precision medicine and fertility, and MEFS’ focus on enhancing reproductive care in the Middle East, we can transform the landscape of reproductive health in the region.”
In addition to chairing the key panel sessions at MEFS 2024, Dr Awwad will be discussing ‘Platelet-rich plasma PRP and Stem cells novelties in ART: Facts or Fads?’.Dr Avella will be sharing the latest updates from his group’s groundbreaking research at Sidra Medicine focusing the genetic basis of female and male infertility. His second presentation will be ‘The genetics of total fertilization failure’.
MEFS 2024 will serve as a meeting point for physicians, urologists, embryologists, nurses, genetic counselors, and researchers to exchange insights and perspectives, strengthening the fertility care ecosystem.
